DexCom, Inc.
DXCM
Hisse Senetlerindeki Sıralama
#751
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Hisse Fiyatı
$86.01
Son senkronizasyon: 2026-10-19
Piyasa Değeri
$32.45B
Değişim (1 gün)
-0.04%
Değişim (1 yıl)
25.68%
Ülke
US
Ticaret DexCom, Inc. (DXCM)
Kategori
Healthcare
DexCom, Inc. (DXCM) için kazanç
Jun 2026 itibarıyla kazanç TTM: $1.28B
DexCom, Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı $1.28B'dir. 2024 yılında şirket $709.00M kazanç elde etti, bu 2023 yılındaki $710.40M kazanca göre önceki yıla göre azalma. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
DexCom, Inc. için kazanç geçmişi 2000 - 2026
Her yılın sonundaki kazanç
| Yıl | Kazanç | Değiştir |
|---|---|---|
| 2026 (TTM) | $1.28B | 17.60% |
| 2025 | $1.09B | 53.51% |
| 2024 | $709.00M | -0.20% |
| 2023 | $710.40M | 81.78% |
| 2022 | $390.80M | 52.18% |
| 2021 | $256.80M | 14.13% |
| 2020 | $225.00M | 115.93% |
| 2019 | $104.20M | -182.37% |
| 2018 | $-126.50M | 160.29% |
| 2017 | $-48.60M | -25.12% |
| 2016 | $-64.90M | 12.87% |
| 2015 | $-57.50M | 157.85% |
| 2014 | $-22.30M | -25.17% |
| 2013 | $-29.80M | -46.59% |
| 2012 | $-55.80M | 24.70% |
| 2011 | $-44.75M | -18.89% |
| 2010 | $-55.17M | 3.08% |
| 2009 | $-53.52M | -3.01% |
| 2008 | $-55.18M | 20.28% |
| 2007 | $-45.88M | -1.55% |
| 2006 | $-46.60M | -99.85% |
| 2005 | $-30.89B | 0.00% |
| 2004 | 0.00 | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
| 2001 | 0.00 | 0.00% |
| 2000 | 0.00 | 0.00% |
Benzer şirketler veya rakipler için kazanç
| Şirket | Kazanç | Kazanç Farkı | Ülke |
|---|---|---|---|
| $7.51B | 486.80% |
US
|
|
| $5.56B | 334.61% |
IE
|
|
| $5.15B | 302.19% |
US
|
|
| $3.86B | 201.64% |
US
|
|
| - | - |
DE
|
